Plasma Device for Selective Treatment of Electroporated Cells

Simple SummaryContent extracted from patent full text and abstract with AI.

The invention presents a method and a device that treats living cells by combining cold atmospheric pressure plasma with selective electroporation. This combination allows for targeted killing of cancer cells, improved wound healing, and enhanced antimicrobial effects without relying on chemical drugs. By quickly and selectively opening cell membranes with electrical pulses (electroporation), plasma-generated reactive species can target and destroy unwanted cells or microbes more efficiently.

Use CasesContent extracted from patent full text and abstract with AI.

• Localized treatment of skin or superficial cancers without using chemotherapeutic drugs.
• Enhanced healing of chronic wounds by promoting tissue regeneration and providing antiseptic treatment.
• More effective sterilization and decontamination of sensitive medical devices or instruments, especially those that cannot tolerate heat or chemicals.

BenefitsContent extracted from patent full text and abstract with AI.

• Targets and destroys cancer cells without the side effects associated with chemotherapy.
• Improves healing of chronic wounds by combining disinfection with stimulation of healthy tissue regrowth.
• Provides a chemical-free, gentle, and effective sterilization method for sensitive medical equipment.
• Reduces treatment costs by eliminating expensive drugs and minimizing side effects and complications.
• Offers universal and more coordinated treatment options for wound management, overcoming inefficiencies in current therapies.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The invention relates to a method and device for treating living cells by way of a cold atmospheric pressure plasma with simultaneous selective electroporation of the cells for local, selective killing of cancer cells, improving the wound treatment and for an improved antimicrobial plasma effect.